Results of radiation therapy for uterine cervical cancer using high dose rate remote after loading system. 2003

Yoshihiro Ogawa, and Kenji Nemoto, and Yoshihisa Kakuto, and Hisanori Ariga, and Haruo Matsushita, and Ken Takeda, and Chiaki Takahashi, and Britton Gallardo, and Keith Richard, and Yoshihiro Takai, and Shogo Yamada
Department of Radiation Oncology, Tohoku University Graduate School of Medicine Sendai 980-8574, Japan. ogaway@rad.med.tohoku.ac.jp

In Japan, radiotherapy with high dose rate remote after loading system (HDR-RALS) for intracavitary brachytherapy is the standard treatment for more than 30 years. This report showed the usefulness of HDR-RALS for uterine cervical cancer. From 1980 through 1999, 442 patients with uterine cervical cancers (stage I: 66, stage II: 161, stage III: 165, stage IV: 50) were treated. Radiotherapy was performed both external teletherapy and HDR-RALS. Overall survival rate at 5 years was 60.2%. The 5-year actuarial incidence of all complications was 16.4%. The 5-year actuarial incidence of all complications in cases treated with the sum doses of whole pelvic irradiation (without central shield) and RALS up to 49 Gy, 50 to 59 Gy or larger doses were 7.5%, 11.0% and 25.2%, respectively. Radiation therapy using HDR-RALS was very effective. While the dose of whole pelvic irradiation was increased, the actuarial incidence of all complications was increased.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011829 Radiation Dosage The amount of radiation energy that is deposited in a unit mass of material, such as tissues of plants or animal. In RADIOTHERAPY, radiation dosage is expressed in gray units (Gy). In RADIOLOGIC HEALTH, the dosage is expressed by the product of absorbed dose (Gy) and quality factor (a function of linear energy transfer), and is called radiation dose equivalent in sievert units (Sv). Sievert Units,Dosage, Radiation,Gray Units,Gy Radiation,Sv Radiation Dose Equivalent,Dosages, Radiation,Radiation Dosages,Units, Gray,Units, Sievert
D001918 Brachytherapy A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. Curietherapy,Implant Radiotherapy,Plaque Therapy, Radioisotope,Radioisotope Brachytherapy,Radiotherapy, Interstitial,Radiotherapy, Intracavity,Radiotherapy, Surface,Brachytherapy, Radioisotope,Interstitial Radiotherapy,Intracavity Radiotherapy,Radioisotope Plaque Therapy,Radiotherapy, Implant,Surface Radiotherapy,Therapy, Radioisotope Plaque
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000206 Actuarial Analysis The application of probability and statistical methods to calculate the risk of occurrence of any event, such as onset of illness, recurrent disease, hospitalization, disability, or death. It may include calculation of the anticipated money costs of such events and of the premiums necessary to provide for payment of such costs. Analysis, Actuarial,Actuarial Analyses,Analyses, Actuarial

Related Publications

Yoshihiro Ogawa, and Kenji Nemoto, and Yoshihisa Kakuto, and Hisanori Ariga, and Haruo Matsushita, and Ken Takeda, and Chiaki Takahashi, and Britton Gallardo, and Keith Richard, and Yoshihiro Takai, and Shogo Yamada
November 2007, AORN journal,
Yoshihiro Ogawa, and Kenji Nemoto, and Yoshihisa Kakuto, and Hisanori Ariga, and Haruo Matsushita, and Ken Takeda, and Chiaki Takahashi, and Britton Gallardo, and Keith Richard, and Yoshihiro Takai, and Shogo Yamada
January 1992, Cancer,
Yoshihiro Ogawa, and Kenji Nemoto, and Yoshihisa Kakuto, and Hisanori Ariga, and Haruo Matsushita, and Ken Takeda, and Chiaki Takahashi, and Britton Gallardo, and Keith Richard, and Yoshihiro Takai, and Shogo Yamada
January 1988, Sonderbande zur Strahlentherapie und Onkologie,
Yoshihiro Ogawa, and Kenji Nemoto, and Yoshihisa Kakuto, and Hisanori Ariga, and Haruo Matsushita, and Ken Takeda, and Chiaki Takahashi, and Britton Gallardo, and Keith Richard, and Yoshihiro Takai, and Shogo Yamada
November 2011, Journal of pediatric surgery,
Yoshihiro Ogawa, and Kenji Nemoto, and Yoshihisa Kakuto, and Hisanori Ariga, and Haruo Matsushita, and Ken Takeda, and Chiaki Takahashi, and Britton Gallardo, and Keith Richard, and Yoshihiro Takai, and Shogo Yamada
March 2005, Gynecologic oncology,
Yoshihiro Ogawa, and Kenji Nemoto, and Yoshihisa Kakuto, and Hisanori Ariga, and Haruo Matsushita, and Ken Takeda, and Chiaki Takahashi, and Britton Gallardo, and Keith Richard, and Yoshihiro Takai, and Shogo Yamada
May 1994, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
Yoshihiro Ogawa, and Kenji Nemoto, and Yoshihisa Kakuto, and Hisanori Ariga, and Haruo Matsushita, and Ken Takeda, and Chiaki Takahashi, and Britton Gallardo, and Keith Richard, and Yoshihiro Takai, and Shogo Yamada
January 2015, Brachytherapy,
Yoshihiro Ogawa, and Kenji Nemoto, and Yoshihisa Kakuto, and Hisanori Ariga, and Haruo Matsushita, and Ken Takeda, and Chiaki Takahashi, and Britton Gallardo, and Keith Richard, and Yoshihiro Takai, and Shogo Yamada
January 1992, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
Yoshihiro Ogawa, and Kenji Nemoto, and Yoshihisa Kakuto, and Hisanori Ariga, and Haruo Matsushita, and Ken Takeda, and Chiaki Takahashi, and Britton Gallardo, and Keith Richard, and Yoshihiro Takai, and Shogo Yamada
July 1987, Nihon Gan Chiryo Gakkai shi,
Yoshihiro Ogawa, and Kenji Nemoto, and Yoshihisa Kakuto, and Hisanori Ariga, and Haruo Matsushita, and Ken Takeda, and Chiaki Takahashi, and Britton Gallardo, and Keith Richard, and Yoshihiro Takai, and Shogo Yamada
January 1990, Gastrointestinal endoscopy,
Copied contents to your clipboard!